from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3431c/-

LFCtreatmentdescriptionclass of inhibitor

-0.468

Amikacinug/mL Amikacintranslation

-0.235

Cap5-10ug/mL Capreomycintranslation

-1.147

Rox10-50 ug/mL Roxithromycintranslation

-1.277

SM2-5 ug/mL Streptomycintranslation

2.121

Tet5-10 ug/mL Tetracyclinetranslation

0.627

Rif0.2-5ug/mL Rifampicintranscription

0.352

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.304

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.534

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.723

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.276

Clofazimine10-13 ug/mL Clofaziminerespiration

0.838

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.880

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.049

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.209

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.269

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.025

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.684

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.386

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.367

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.504

KCN5-20 ug/mL Potassium cyaniderespiration

-0.691

NaN30.2-2 mM Sodium aziderespiration

-1.047

Nigericin50 uM Nigericinrespiration

0.955

TRC10-150 ug/mL Triclosanrespiration

0.832

TRZ10-25 ug/mL Thioridazinerespiration

-0.211

Valinomycin0.5-10 uM Valinomycinrespiration

0.061

ZnSO42 mM ZnSO4respiration

0.875

menadione6-10 ug/mL Menadionerespiration

0.083

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.021

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.326

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.170

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.805

NRP_1Non-replicating persistence stage 1dosRassociated

0.173

Amp0.2mg/mL AmpicillincellWall

0.343

Cephalexin20-100 ug/mL CephalexincellWall

0.964

Cerulenin0.32-5 ug/mL CerulenincellWall

0.501

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.336

EMB10-20 ug/mL EthambutolcellWall

-0.310

Eta12-40 ug/mL EthionamidecellWall

-0.451

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.106

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.793

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.765

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.317

BZA0.12 mg/mL BenzamidearomaticAmides

0.103

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.630

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.306

H2O24 mM hydrogen peroxideDNAdamaging

-0.360

Levo10 ug/mL LevofloxacinDNAdamaging

-0.465

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.899

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.507

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.556

UVUV-irradiationDNAdamaging

0.882

ARP41-4 ug/mL Antitubercular compound ARP4?

0.419

Antimycin12.5-50 ug/mL Antimycin A?

-0.051

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.276

PA_110-50 ug/mL Antitubercular compound PA-1?

0.374

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.036

PA8240.2-2 ug/mL PA-824?

0.257

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.659

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.422

Verapamil50 uM Verapamil?

-0.088

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.124

methoxatin10-20 ug/mL Methoxatin?